LeMaitre Vascular Analyst Price Targets

Wall Street analyst price targets and consensus rating for LeMaitre Vascular (LMAT).

Price Target Range — 10 Quarters

Analyst Consensus — 10 Analysts

2S.Buy

7Buy

1Hold

Consensus RatingBuy# Analysts10Avg. Consensus PT$104Upside to Avg. PT+26.6%

Rating Trend — Last 9 Months

Recent Analyst Actions

See all ratings →

Date	Firm	Analyst	Action	Rating Change	Price Target
Aug 5, 2026	Wells Fargo	Nathan Treybeck	PT Cut	Equal-Weight	$104→$94
Jun 3, 2026	Barrington Research	Michael Petusky	Maintained	Outperform	$120
May 6, 2026	Barrington Research	Michael Petusky	PT Raise	Outperform	$105→$120
May 6, 2026	Citizens	Daniel Stauder	PT Raise	Market Outperform	$118→$127
May 6, 2026	Wells Fargo	Nathan Treybeck	PT Raise	Equal-Weight	$94→$104
Feb 26, 2026	Barrington Research	Michael Petusky	PT Raise	Outperform	$95→$105
Feb 26, 2026	Roth Capital	Kyle Bauser	PT Raise	Buy	$108→$117
Feb 26, 2026	Wells Fargo	Nathan Treybeck	PT Raise	Equal-Weight	$87→$94
Feb 26, 2026	Citizens	Daniel Stauder	PT Raise	Market Outperform	$113→$118
Feb 20, 2026	Barrington Research	Michael Petusky	Maintained	Outperform	$95
Nov 7, 2025	Wells Fargo	Nathan Treybeck	PT Cut	Equal-Weight	$97→$93
Nov 5, 2025	Roth Capital	Kyle Bauser	Reinstates	Buy	$108
Oct 15, 2025	Barrington Research	Michael Petusky	Maintained	Outperform	$95
Sep 23, 2025	Barrington Research	Michael Petusky	Maintained	Outperform	$95
Aug 6, 2025	Cantor Fitzgerald	Ross Osborn	PT Raise	Neutral	$92→$95
Aug 6, 2025	Barrington Research	Michael Petusky	Upgrade	Market Perform→Outperform	$95
Jul 22, 2025	Barrington Research	Michael Petusky	Maintained	Market Perform	—
Feb 28, 2025	Lake Street	Brooks O'Neil	PT Raise	Buy	$105→$110
Feb 28, 2025	Citizens Capital Markets	Daniel Stauder	PT Raise	Buy	$105→$110
Feb 28, 2025	Barrington Research	Michael Petusky	Downgrade	Outperform→Market Perform	—

Analyst Ratings News

PRO
Wells Fargo Maintains Equal-Weight on LeMaitre Vascular, Lowers Price Target to $94

Wells Fargo analyst Nathan Treybeck maintains LeMaitre Vascular (NASDAQ:LMAT) with a Equal-Weight and lowers the price target from $104 to $94.

Benzinga Newsdesk

PRO
Barrington Research Maintains Outperform on LeMaitre Vascular, Raises Price Target to $120

Barrington Research analyst Michael Petusky maintains LeMaitre Vascular (NASDAQ:LMAT) with a Outperform and raises the price target from $105 to $120.

Benzinga Newsdesk

PRO
Citizens Maintains Market Outperform on LeMaitre Vascular, Raises Price Target to $127

Citizens analyst Daniel Stauder maintains LeMaitre Vascular (NASDAQ:LMAT) with a Market Outperform and raises the price target from $118 to $127.

Benzinga Newsdesk

PRO
Wells Fargo Maintains Equal-Weight on LeMaitre Vascular, Raises Price Target to $104

Wells Fargo analyst Nathan Treybeck maintains LeMaitre Vascular (NASDAQ:LMAT) with a Equal-Weight and raises the price target from $94 to $104.

Benzinga Newsdesk

PRO
Barrington Research Maintains Outperform on LeMaitre Vascular, Raises Price Target to $105

Barrington Research analyst Michael Petusky maintains LeMaitre Vascular (NASDAQ:LMAT) with a Outperform and raises the price target from $95 to $105.

Benzinga Newsdesk

Breaking Down LeMaitre Vascular: 4 Analysts Share Their Views

Benzinga Insights

LeMaitre Vascular Inc

LeMaitre Vascular Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PRO
Wells Fargo Maintains Equal-Weight on LeMaitre Vascular, Lowers Price Target to $94

PRO
Barrington Research Maintains Outperform on LeMaitre Vascular, Raises Price Target to $120

PRO
Citizens Maintains Market Outperform on LeMaitre Vascular, Raises Price Target to $127

PRO
Wells Fargo Maintains Equal-Weight on LeMaitre Vascular, Raises Price Target to $104

PRO
Barrington Research Maintains Outperform on LeMaitre Vascular, Raises Price Target to $105

Breaking Down LeMaitre Vascular: 4 Analysts Share Their Views

People Also Watch

People Also Watch

LeMaitre Vascular Inc

LeMaitre Vascular Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PROWells Fargo Maintains Equal-Weight on LeMaitre Vascular, Lowers Price Target to $94

PROBarrington Research Maintains Outperform on LeMaitre Vascular, Raises Price Target to $120

PROCitizens Maintains Market Outperform on LeMaitre Vascular, Raises Price Target to $127

PROWells Fargo Maintains Equal-Weight on LeMaitre Vascular, Raises Price Target to $104

PROBarrington Research Maintains Outperform on LeMaitre Vascular, Raises Price Target to $105

Breaking Down LeMaitre Vascular: 4 Analysts Share Their Views

People Also Watch

People Also Watch

PRO
Wells Fargo Maintains Equal-Weight on LeMaitre Vascular, Lowers Price Target to $94

PRO
Barrington Research Maintains Outperform on LeMaitre Vascular, Raises Price Target to $120

PRO
Citizens Maintains Market Outperform on LeMaitre Vascular, Raises Price Target to $127

PRO
Wells Fargo Maintains Equal-Weight on LeMaitre Vascular, Raises Price Target to $104

PRO
Barrington Research Maintains Outperform on LeMaitre Vascular, Raises Price Target to $105